At the preclinical stage, 6–11 years before the onset of AD, neuronal-exosomal levels of synaptic proteins including neurexin 2α, GluA4-containing glutamate receptor, and neuroligin 1 were significantly reduced in AD compared to age-matched controls [78]. Here, NLGN1 is linked to Alzheimer disease.